The exploration of standardized operation of laboratory medicine in China has stepped to a new level

Release time:


Recently, China's first standardized operation standard for the pre analysis of laboratory medical specimens, the Consensus on the Pre analysis Standard of Blood Specimens in China's Clinical Laboratory, was officially released in Shanghai. The Consensus was jointly formulated by 24 domestic front-line laboratory medical experts, which not only refined the relevant domestic laws and regulations and accreditation standards at the operational level, but also fully considered and connected with the internationally accepted standards and specifications. The release of the Consensus marks a new step in the exploration of standardized operation of laboratory medicine in China, and provides a practical operation guide for medical personnel in clinical laboratories and related departments. The Consensus was jointly supported by the Chinese Journal of Laboratory Medicine and the world leading medical technology company BD.
Professor Fu Weiling, Chairman of the Military Laboratory Medical Committee and Director of the Laboratory Department of the First Affiliated Hospital (Southwest Hospital) of the Third Military Medical University, said, "We see that despite the introduction of advanced medical equipment and scientific experimental technology, there is a certain gap between our management and that of world-class medical laboratories, especially in the absence of a general, detailed and clear guide to action at the specific practical level. Against this background, the Consensus It has emerged at the historic moment and is committed to achieving "four benefits", that is, to become a useful supplement and extension of relevant laws and regulations and recognition standards, a useful exploration of standardization and internationalization of laboratory medicine management mode, a useful reference and guidance for the personal development of relevant departments and medical personnel, and a useful driving force for the improvement of patient diagnosis and treatment effects. "
The quality control of clinical laboratory is divided into three links: quality control before analysis, which refers to the quality management in the process of doctors selecting test items and putting forward test applications, patient preparation, specimen collection and transportation; Quality control in analysis refers to the indoor quality control of the laboratory; The post analysis quality control refers to the reasonable analysis and interpretation of the results and the connection with the clinic. Statistics show that among the cases that can analyze the causes of test errors, the errors from the pre analysis stage account for about 65%. This is mainly due to the long time before analysis, the complexity of participants, and many variable factors. The pre analysis stage accounts for about 60% of the whole inspection process. Participants include clinicians, nursing staff, transportation personnel, patients themselves, etc. Therefore, many factors will have a certain impact on the final inspection results. Therefore, the first consensus in China is specifically aimed at the stage of 'pre analysis of blood samples'. The quality assurance in this stage is the most important and critical link in the clinical inspection quality assurance system, and is the basis for ensuring the accuracy, reliability and effectiveness of clinical inspection results.
The Consensus was initiated and formulated by 24 front-line laboratory medical experts from Beijing, Shanghai and other provinces and cities. The Consensus is divided into nine chapters and thirty-six sections, covering the operation specifications of the whole process before analysis, including clinical blood sample collection site and environmental requirements, test application and sample collection preparation, venous, arterial and peripheral blood collection process, sample transportation, reception, treatment and storage, the impact of blood collection appliances on the test results, quality assurance and safety precautions. Professor Li Yan, Director of Laboratory Department of Hubei Provincial People's Hospital, said: "Consensus" By providing scientific, systematic and comprehensive operation specifications, clinicians, nursing staff and patients in all departments can work together more closely to form a joint force and work together to reduce test errors and improve diagnosis and treatment efficiency. The establishment of this cooperation mode will not only help improve the quality of inspection, but also further reduce unnecessary or repeated waste of resources, help doctors and patients understand and trust each other, and achieve a double harvest of economic and social benefits. "
Dr. Cen Guoshan, Business Director of Specimen Analysis and Preprocessing System of BD Greater China, said: "It's a great honor to support and witness the Consensus Release of. It can be said that this is another important milestone in the development of laboratory medicine in China. BD set up a branch in China in 1994. Its business covers all aspects of medical care and laboratory diagnosis, and provides comprehensive solutions for clinical diagnosis and scientific research in the sample pretreatment stage, including comprehensive product portfolio, technical platform, clinical education and professional training. In the future, we will continue to support the improvement of China's medical laboratory standards to achieve sustainable development. "
This article comes from: Laboratory Frontier - a website focusing only on the laboratory.